治疗相关骨髓增生异常综合征和急性髓系白血病中的异柠檬酸脱氢酶1（IDH1）和异柠檬酸脱氢酶2（IDH2）突变与正常核型以及der(1;7)(q10;p10)相关。 - Suppr

Suppr

超能文献

IDH1 and IDH2 mutations in therapy-related myelodysplastic syndrome and acute myeloid leukemia are associated with a normal karyotype and with der(1;7)(q10;p10).

作者信息

Westman M K, Pedersen-Bjergaard J, Andersen M T, Andersen M K

出版信息

Leukemia. 2013 Apr;27(4):957-9. doi: 10.1038/leu.2012.347. Epub 2012 Nov 29.

DOI:10.1038/leu.2012.347

PMID:23192014

Abstract

摘要

相似文献

IDH1 and IDH2 mutations in therapy-related myelodysplastic syndrome and acute myeloid leukemia are associated with a normal karyotype and with der(1;7)(q10;p10).治疗相关骨髓增生异常综合征和急性髓系白血病中的异柠檬酸脱氢酶1（IDH1）和异柠檬酸脱氢酶2（IDH2）突变与正常核型以及der(1;7)(q10;p10)相关。

Leukemia. 2013 Apr;27(4):957-9. doi: 10.1038/leu.2012.347. Epub 2012 Nov 29.

Clinicopathological features of unbalanced translocation Der(1;7)(q10;p10) in myeloid neoplasms.髓系肿瘤中不平衡易位Der(1;7)(q10;p10)的临床病理特征

Leuk Res. 2008 Jun;32(6):1000-1. doi: 10.1016/j.leukres.2007.09.019. Epub 2007 Nov 5.

Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroup.急性髓系白血病（AML）和骨髓增生异常综合征（MDS）中伴有TP53同时突变的der(5;17)(p10;q10)全臂易位：一个独特的分子细胞遗传学亚组。

Cancer Genet. 2016 May;209(5):205-14. doi: 10.1016/j.cancergen.2016.04.001. Epub 2016 Apr 6.

Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms.不平衡易位der(1;7)(q10;p10)定义了髓系肿瘤的一个独特的临床病理亚组。

Leukemia. 2007 May;21(5):992-7. doi: 10.1038/sj.leu.2404619. Epub 2007 Feb 22.

IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.中国急性髓系白血病和骨髓增生异常综合征患者的 IDH1 和 IDH2 突变分析。

Ann Hematol. 2012 Apr;91(4):519-25. doi: 10.1007/s00277-011-1352-7. Epub 2011 Oct 14.

[der(1;7) (q10;p10) in three patients with malignant hematologic disorders].[三名恶性血液系统疾病患者中的(1;7)(q10;p10)]

Rinsho Ketsueki. 1992 Dec;33(12):1829-33.

Clonal leukemic evolution in myelodysplastic syndromes with TET2 and IDH1/2 mutations.伴 TET2 和 IDH1/2 突变的骨髓增生异常综合征中的克隆性白血病演变。

Haematologica. 2014 Jan;99(1):28-36. doi: 10.3324/haematol.2013.091249. Epub 2013 Aug 30.

Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.通过靶向二代测序检测急性髓系白血病和骨髓增生异常综合征中的双IDH1和IDH2突变

J Mol Diagn. 2015 Nov;17(6):661-8. doi: 10.1016/j.jmoldx.2015.06.004. Epub 2015 Aug 30.

Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q).高危骨髓增生异常综合征或伴有孤立性5号染色体长臂缺失的急性髓系白血病中的复发性异柠檬酸脱氢酶突变

Leukemia. 2010 Jul;24(7):1370-2. doi: 10.1038/leu.2010.98. Epub 2010 May 20.

Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients.新诊断的急性髓系白血病患者中异柠檬酸脱氢酶 1 和 2（IDH1 和 IDH2）代谢基因的分子改变和其他基因突变。

J Hematol Oncol. 2012 Mar 7;5:5. doi: 10.1186/1756-8722-5-5.

引用本文的文献

Genetic Landscape and Risk Stratification of AML With Hyperdiploid Karyotype.伴有超二倍体核型的急性髓系白血病的遗传图谱与风险分层

Eur J Haematol. 2025 Aug;115(2):165-175. doi: 10.1111/ejh.14434. Epub 2025 May 12.

Blood Cancer Discov. 2024 Nov 1;5(6):400-416. doi: 10.1158/2643-3230.BCD-24-0103.

Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias.骨髓增生异常综合征和急性髓系白血病中的异柠檬酸脱氢酶突变

Cancers (Basel). 2020 Aug 26;12(9):2427. doi: 10.3390/cancers12092427.

Prognostic Markers of Myelodysplastic Syndromes.骨髓增生异常综合征的预后标志物。

Medicina (Kaunas). 2020 Jul 27;56(8):376. doi: 10.3390/medicina56080376.

Genetic Pathway in the Pathogenesis of Therapy-Related Myeloid Neoplasms: A Literature Review.治疗相关髓系肿瘤发病机制中的遗传通路：文献综述

Oncol Ther. 2020 Jun;8(1):45-57. doi: 10.1007/s40487-020-00111-7. Epub 2020 Mar 16.

promoter methylation as a potential prognostic marker for acute leukemia.启动子甲基化作为急性白血病的潜在预后标志物。

Arch Med Sci. 2017 Oct;13(6):1433-1441. doi: 10.5114/aoms.2017.71067. Epub 2017 Oct 31.

High frequency of RUNX1 mutation in myelodysplastic syndrome patients with whole-arm translocation of der(1;7)(q10;p10).伴有der(1;7)(q10;p10)全臂易位的骨髓增生异常综合征患者中RUNX1突变的高频率

Leukemia. 2017 Oct;31(10):2257-2260. doi: 10.1038/leu.2017.228. Epub 2017 Jul 19.

Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents - A Potential Therapy for Cancer.用DNA去甲基化剂增强PARP抑制剂的细胞毒性作用——一种潜在的癌症治疗方法

Cancer Cell. 2016 Oct 10;30(4):637-650. doi: 10.1016/j.ccell.2016.09.002.

Rare cytogenetic abnormalities in myelodysplastic syndromes.骨髓增生异常综合征中的罕见细胞遗传学异常

Mediterr J Hematol Infect Dis. 2015 May 1;7(1):e2015034. doi: 10.4084/MJHID.2015.034. eCollection 2015.

Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.通过下一代测序技术对治疗相关骨髓增生异常综合征和急性髓系白血病进行突变分析，并与初发性疾病进行比较。

Leuk Res. 2015 Mar;39(3):348-54. doi: 10.1016/j.leukres.2014.12.006. Epub 2014 Dec 20.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验